CoChat

Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease

Open access
Dai, Lu, Qureshi, Abdul Rashid, Witasp, Anna, Lindholm, Bengt, Stenvinkel, Peter · 2019 · Computational and Structural Biotechnology Journal
Cited by 94

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Chronic kidney disease (CKD) is a clinical model of premature ageing characterized by progressive vascular disease, systemic inflammation, muscle wasting and frailty. The predominant early vascular ageing (EVA) process mediated by medial vascular calcification (VC) results in a marked discrepancy between chronological and biological vascular age in CKD. Though the exact underlying mechanisms of VC and EVA are not fully elucidated, accumulating evidence indicates that cellular senescence - and subsequent chronic inflammation through the senescence-associated secretary phenotype (SASP) - plays a fundamental role in its initiation and progression. In this review, we discuss the pathophysiological links between senescence and the EVA process in CKD, with focus on cellular senescence and media VC, and potential anti-ageing therapeutic strategies of senolytic drugs targeting cellular senescence and EVA in CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.csbj.2019.06.015

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 77

  1. Kooman J.P., Broers N.J.H., Usvyat L., Thijssen S., Van Der Sande F.M., Cornelis T. et al: Out of control: accelerated aging in uremia. Nephrol Dial Transplant 2013; 28: 48. · DOI
  2. Kooman J.P., Shiels P.G. and Stenvinkel P.: Premature aging in chronic kidney disease and chronic obstructive pulmonary disease: similarities and differences. Curr Opin Clin Nutr Metab Care 2015; 18: 528.
  3. Girndt M. and Seibert E.: Premature cardiovascular disease in chronic renal failure (CRF): a model for an advanced ageing process. Exp Gerontol 2010; 45: 797. · DOI
  4. 10.1038/nrneph.2014.185 · DOI · Paper page
  5. 10.1053/j.ajkd.2012.11.051 · DOI · Paper page
  6. Cunha P.G., Boutouyrie P., Nilsson P.M. and Laurent S.: Early vascular ageing (EVA): definitions and clinical applicability. Curr Hypertens Rev 2017; 13: 1. · DOI
  7. Shanahan C.M.: Mechanisms of vascular calcification in CKD - evidence for premature ageing?. Nat Rev Nephrol 2013; 9: 661. · DOI · Paper page
  8. Shroff R., Long D.A. and Shanahan C.: Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 2013; 24: 179. · DOI · Paper page
  9. McGlynn L.M., Stevenson K., Lamb K., Zino S., Brown M., Prina A. et al: Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell 2009; 8: 45. · DOI
  10. 10.1074/jbc.M409153200 · DOI · Paper page
  11. 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  12. Hayflick L.: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614. · DOI · Paper page
  13. Xia L., Huang Q., Chen X., Yin Z., Zhang Y., Lun L. et al: Youthful systemic milieu alleviates renal ischemia-reperfusion injury in elderly mice. Kidney Int 2018; 94: 268. · DOI
  14. Plotkin M.: Young blood for old kidneys? More questions than answers so far. Kidney Int 2018; 94: 235. · DOI
  15. Keung L. and Perwad F.: Vitamin D and kidney disease. Bone Rep 2018; 9: 93. · DOI
  16. Kim S.-H., Rowe J., Fujii H., Jones R., Schmierer B., Kong B.-W. et al: Upregulation of chicken p15INK4b at senescence and in the developing brain. J Cell Sci 2006; 119: 2435. · DOI · Paper page
  17. 10.1016/j.cell.2013.10.041 · DOI · Paper page
  18. 10.1097/HJH.0b013e3283399326 · DOI
  19. Childs B.G., Baker D.J., Wijshake T., Conover C.A., Campisi J. and van Deursen J.M.: Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science (New York, NY) 2016; 354: 472. · DOI · Paper page
  20. Kooman J.P., Dekker M.J., Usvyat L.A., Kotanko P., van der Sande F.M., Schalkwijk C.G. et al: Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol 2017; 313: F938. · DOI · Paper page
  21. 10.1046/j.1474-9728.2003.00048.x · DOI · Paper page
  22. 10.1038/nbt0702-682 · DOI · Paper page
  23. Brown J.P., Wei W. and Sedivy J.M.: Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (New York, NY) 1997; 277: 831. · DOI · Paper page
  24. Kipling D., Davis T., Ostler E.L. and Faragher R.G.A.: What can progeroid syndromes tell us about human aging?. Science (New York, NY) 2004; 305: 1426. · DOI · Paper page
  25. 10.1038/nm.2014 · DOI · Paper page
  26. 10.1016/j.ccr.2004.09.028 · DOI · Paper page
  27. 10.1046/j.1365-2443.2003.00620.x · DOI · Paper page
  28. 10.1016/j.kint.2018.12.014 · DOI
  29. Anand David A., Arulmoli R. and Parasuraman S.: Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacognosy Reviews 2016; 10: 84. · DOI · Paper page
  30. 10.1021/jm049486a · DOI · Paper page
  31. Xu M., Bradley E.W., Weivoda M.M., Hwang S.M., Pirtskhalava T., Decklever T. et al: Transplanted senescent cells induce an osteoarthritis-like condition in mice. J Gerontol A Biol Sci Med Sci 2017; 72: 780.
  32. Gradin P., Hollberg K., Cassady A.I., Lång P., Andersson G., Lang P. et al: Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density. Cells Tissues Organs 2012; 196: 68. · DOI
  33. Mikhailova M.V., Belyaeva N.F., Kozlova N.I., Zolotarev K.V., Mikhailov A.N., Berman A.E. et al: Protective action of fish muscle extracts against cellular senescence induced by oxidative stress. Biomeditsinskaya Khim 2017; 63: 351. · DOI
  34. Kovacovicova K., Skolnaja M., Heinmaa M., Mistrik M., Pata P., Pata I. et al: Senolytic cocktail Dasatinib+quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer. Front Oncol 2018; 8: 459. · DOI · Paper page
  35. Stenvinkel P., Meyer C.J., Block G.A., Chertow G. and Shiels P.G.: Understanding the role of the cytoprotective transcription factor NRF2 - Lessons from evolution, the animal kingdom and rare progeroid syndromes. Nephrol Dial Transpl 2019; . [In Press].
  36. Covic A., Vervloet M., Massy Z.A., Torres P.U., Goldsmith D., Brandenburg V. et al: Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol 2018; 6: 319. · DOI · Paper page
  37. 10.1016/j.mad.2006.11.015 · DOI · Paper page
  38. Carrero J.J., Stenvinkel P., Fellström B., Qureshi A.R., Lamb K., Heimbürger O. et al: Telomere attrition is associated with inflammation, low fetuin-a levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263: 302. · DOI · Paper page
  39. Carrero J.J. and Stenvinkel P.: Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009; 4: S49. · DOI · Paper page
  40. Yamada S., Tatsumoto N., Tokumoto M., Noguchi H., Ooboshi H., Kitazono T. et al: Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model. Calcif Tissue Int 2015; 96: 347. · DOI
  41. 10.1371/journal.pone.0092115 · DOI
  42. 10.1152/ajprenal.00527.2012 · DOI
  43. 10.18632/aging.101173 · DOI
  44. 10.1053/j.ajkd.2010.12.027 · DOI · Paper page
  45. Drüeke T.B. and Massy Z.A.: Circulating klotho levels: clinical relevance and relationship with tissue klotho expression. Kidney Int 2013; 83: 13. · DOI
  46. Maltese G., Psefteli P.-M., Rizzo B., Srivastava S., Gnudi L., Mann G.E. et al: The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells. J Cell Mol Med 2017; 21: 621. · DOI
  47. 10.1161/HYPERTENSIONAHA.116.07709 · DOI
  48. Makulska I., Szczepańska M., Drożdż D., Polak-Jonkisz D. and Zwolińska D.: The importance of fetuin-A in vascular calcification in children with chronic kidney disease. In: Advances in Clinical and Experimental Medicine. : Official Organ Wroclaw Medical University 2018.
  49. Al-Biltagi M., ElHafez M.A.A., El Amrousy D.M., El-Gamasy M. and El-Serogy H.: Evaluation of the coronary circulation and calcification in children on regular hemodialysis. Pediatr Nephrol (Berlin, Germany) 2017; 32: 1941. · DOI
  50. Shroff R.C., McNair R., Figg N., Skepper J.N., Schurgers L., Gupta A. et al: Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748. · DOI · Paper page
  51. Yamada S., Taniguchi M., Tokumoto M., Toyonaga J., Fujisaki K., Suehiro T. et al: The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Mineral Res 2012; 27: 474. · DOI
  52. McCabe K.M., Booth S.L., Fu X., Shobeiri N., Pang J.J., Adams M.A. et al: Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013; 83: 835. · DOI
  53. 10.1161/CIRCRESAHA.110.234914 · DOI · Paper page
  54. Vaziri N.D.: Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469. · DOI · Paper page
  55. Goettsch C., Weis D., Kramann R., Hellmann B., Floege J., Schurgers L. et al: Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol Dial Transplant 2019; : 1.
  56. Holt S.G. and Smith E.R.: Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease. Nephrol Dial Transplant 2016; 31: 1583. · DOI
  57. Eleftheriadou I., Grigoropoulou P., Kokkinos A., Mourouzis I., Perrea D., Katsilambros N. et al: Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus. J Diabetes Complications 2017; 31: 599. · DOI
  58. Viegas C.S.B., Santos L., Macedo A.L., Matos A.A., Silva A.P., Neves P.L. et al: Chronic kidney disease circulating Calciprotein particles and extracellular vesicles promote vascular calcification: a role for GRP (Gla-rich protein). Arterioscler Thromb Vasc Biol 2018; 38: 575. · DOI
  59. 10.1016/j.yexcr.2016.06.007 · DOI · Paper page
  60. Lin M.-E., Chen T., Leaf E.M., Speer M.Y. and Giachelli C.M.: Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol 2015; 185: 1958. · DOI
  61. Sun Y., Byon C.H., Yuan K., Chen J., Mao X., Heath J.M. et al: Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res 2012; 111: 543. · DOI · Paper page
  62. Voelkl J., Lang F., Eckardt K.-U., Amann K., Kuro-O M., Pasch A. et al: Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci 2019; 76: 2077.
  63. Voelkl J., Tuffaha R., Luong T.T.D.D., Zickler D., Masyout J., Feger M. et al: Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-kappaB. J Am Soc Nephrol 2018; 29: 1636. · DOI · Paper page
  64. Xu Z., Ji G., Shen J., Wang X., Zhou J. and Li L.: SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. Biochem Biophys Res Commun 2012; 422: 285. · DOI
  65. Voelkl J., Luong T.T.D.T., Tuffaha R., Musculus K., Auer T., Lian X. et al: SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling. J Clin Investig 2018; 128: 3024. · DOI · Paper page
  66. Giachelli C.M.: The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890. · DOI · Paper page
  67. Opdebeeck B., Maudsley S., Azmi A., De Maré A., De Leger W., Meijers B. et al: Indoxyl sulfate and p-Cresyl sulfate promote vascular calcification and associate with glucose intolerance. J Am Soc Nephrol 2019; . ASN.2018060609. · DOI · Paper page
  68. Iyemere V.P., Proudfoot D., Weissberg P.L. and Shanahan C.M.: Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006; 260: 192. · DOI · Paper page
  69. 10.1161/CIRCULATIONAHA.109.902056 · DOI · Paper page
  70. Liu Y., Drozdov I., Shroff R., Beltran L.E. and Shanahan C.M.: Prelamin a accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res 2013; 112: e99.
  71. Song Y., Shen H., Schenten D., Shan P., Lee P.J. and Goldstein D.R.: Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2012; 32: 103. · DOI
  72. 10.1073/pnas.0511133103 · DOI · Paper page
  73. 10.1152/ajpcell.00329.2011 · DOI
  74. 10.1038/nrneph.2017.169 · DOI
  75. Jazani NH Savoj J Lustgarten M Lau WL Vaziri ND. Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease. Diseases (Basel Switzerland) 2019;7. doi:https://doi.org/10.3390/diseases7010021. · DOI
  76. Tchkonia T. and Kirkland J.L.: Therapeutic approaches to aging-reply. JAMA 2019; 321: 901. · DOI
  77. Ridker P.M., MacFadyen J.G., Glynn R.J., Koenig W., Libby P., Everett B.M. et al: Inhibition of interleukin-1β by Canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol 2018; 71: 2405. · DOI · Paper page

Cited by

See all 94

Metadata

Authors
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P.
Venue
Computational and Structural Biotechnology Journal
Published
2019
Volume
17
Pages
721-729
ISSN
2001-0370 (ISSN-L)
OpenAlex
W2950937096
Cited by
94
References
46
FWCI
7.86
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • H2020 Marie Skłodowska-Curie Actions (722609)
  • Vetenskapsrådet (2009-1068)
  • Karolinska Institutet

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease. https://app.cochat.ai/papers/10.1016/j.csbj.2019.06.015
The paper
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P. (2019). Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease. Computational and Structural Biotechnology Journal. https://doi.org/10.1016/j.csbj.2019.06.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.